Allarta Life Science Moves Canadian-developed Type 1 Diabetes Cell Therapy Closer to the Clinic with Breakthrough T1D Award
November 16, 2026
November 16, 2026
NEW YORK, Nov. 16 -- Breakthrough T1D (formerly JDRF) a non-profit dedicated to funding type 1 diabetes research, posted the following news release:
* * *
Allarta Life Science Moves Canadian-developed Type 1 Diabetes Cell Therapy Closer to the Clinic with Breakthrough T1D Award
*
Announced during Diabetes Awareness Month, the award marks significant progress for type 1 diabetes cell therapies
HAMILTON, Ont., Nov. 16, 2026 - Allarta . . .
* * *
Allarta Life Science Moves Canadian-developed Type 1 Diabetes Cell Therapy Closer to the Clinic with Breakthrough T1D Award
*
Announced during Diabetes Awareness Month, the award marks significant progress for type 1 diabetes cell therapies
HAMILTON, Ont., Nov. 16, 2026 - Allarta . . .
